Integrin αvβ6-targeted PET in Malignant Tumors

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

December 30, 2025

Conditions
Malignant NeoplasmPET/CTNon-Small Cell Lung CancerBreast Cancer, Metastatic
Interventions
DIAGNOSTIC_TEST

PET/CT scans

Diagnostic Test: For 68Ga-Trivehexin PET/CT, no special preparation was required. Approximately 50 min after an i.v. administration of \[68Ga\]Ga-Trivehexin with a dose of 1.85-2.22 MBq/kg, and the PET acquisition time was 2.5 min per bed.

Trial Locations (1)

430071

RECRUITING

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Zhongnan Hospital

OTHER